• Touyun Biotech Group entered a subscription agreement to issue 123,000,000 new shares at HK$ 0.122 each.
• Deal size HK$ 15.01 million gross proceeds; HK$ 14.99 million net proceeds.
• Pricing implies an 18.67% discount to the HK$ 0.15 close on the agreement date.
• New shares equal about 4.38% of existing share capital; about 4.2% on an enlarged basis.
• Proceeds earmarked for general working capital; completion expected within five business days once conditions are met.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Touyun Biotech Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260825-12298730), on August 25, 2026, and is solely responsible for the information contained therein.